Postgraduate Medical Journal · 1996 · 55 citations · 5 references
MedicinePharmacologyPharmacotherapyChemotherapyClinical PharmacologyGastrointestinal PharmacotherapyAntiemetic PharmacologyAntiemetic TherapyHyperemesis GravidarumNausea ControlNausea ManagementVomiting Management5-Hydroxytryptamine 3 Receptor Antagonists5-Hydroxytryptamine Receptor PharmacologyAnti-emetic ProphylaxisHyperemesis Gravidarum Nutrition SupportObstetric Antiemetic UseParenteral Nutrition AdministrationPostoperative Nausea ManagementTreatment Adverse Effects
Ondansetron is a 5-hydroxytryptamine receptor antagonist which is known to be a highly effective anti-emetic drug for chemotherapy-associated nausea and vomiting and for postoperative nausea. We report here a case where ondansetron was used in severe hyperemesis gravidarum to avoid parenteral nutrition. The drug was used intermittently in every trimester with no apparent adverse effects on mother or infant.
5
Ondansetron in the Treatment of Postoperative Vomiting
Eli Alon, Sabine Himmelseher · Anesthesia & Analgesia · 1992 · 150 citations
The clinical pharmacology of ondansetron.
C P Blackwell, Stuart M. Harding · PubMed · 1989 · 83 citations
Pharmacological and anti-emetic properties of ondansetron.
M.B. Tyers, K T Bunce, P.P.A. Humphrey · PubMed · 1989 · 61 citations
Ondansetron in the prophylaxis of acute cisplatin-induced nausea and vomiting.
Michel Marty · PubMed · 1989 · 44 citations
Medicine, Oncology, Pharmacotherapy +12